Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Rheumatology
•
Vasculitis
•
GCA
What imaging do you prefer for screening of large vessel involvement in GCA and do you routinely get that in all newly diagnosed cases?
Related Questions
How would you approach a patient with GCA who develops necrotizing fasciitis and then flares because they are off of tocilizumab?
Do you routinely obtain baseline vascular imaging (CTA, MRA, PET) in patients with suspected GCA, but negative temporal artery biopsy?
How would you interpret a temporal artery biopsy demonstrating focal chronic inflammation in the adventitia associated with small adventitial vessels and nerves without inflammation of the intima and media and without giant cells?
How long do you continue PJP prophylaxis in a patient with GPA who is able to wean steroids and remains only on rituximab for maintenance therapy?
Is a persistently elevated IgE level clinically relevant in a patient who has otherwise good control of EGPA and completely suppressed eosinophils on mepolizumab?
How would you approach the work up of a patient with nasal septal perforation, a negative infectious workup, and negative ANCA titers?
Would you approach a patient with idiopathic bilateral sensorineural hearing loss and episcleritis as atypical Cogan’s syndrome even in the absence of MRI/ MRA changes and minimal elevation of inflammation markers?
Do you recommend monitoring IgG level in patients with AAV receiving rituximab?
How would you approach clinically isolated aortitis in a patient with recent head and neck cancer currently in remission?
When do you consider Mesna for patients taking oral cyclophosphamide?
